UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036540
Receipt number R000041633
Scientific Title A validation study of efficacy of image fusion technique using magnetic position tracking system (Real-time virtual sonography or Volume navigation) for the localization of breast cancer with non-mass enhancement in breast conserving surgery (prospective multicenter study) : FUSION 02 study
Date of disclosure of the study information 2019/09/01
Last modified on 2020/10/20 18:15:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A validation study of efficacy of image fusion technique using magnetic position tracking system (Real-time virtual sonography or Volume navigation) for the localization of breast cancer with non-mass enhancement in breast conserving surgery (prospective multicenter study) : FUSION 02 study

Acronym

FUSION 02 study

Scientific Title

A validation study of efficacy of image fusion technique using magnetic position tracking system (Real-time virtual sonography or Volume navigation) for the localization of breast cancer with non-mass enhancement in breast conserving surgery (prospective multicenter study) : FUSION 02 study

Scientific Title:Acronym

FUSION 02 study

Region

Japan


Condition

Condition

Breast cancer with non-mass enhancement (NME) detected by MRI

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether Real-time virtual sonography (RVS)/Volume navigation (Vnav) contribute to the improvement of margin positive rate of breast cancer with NME in breast conserving surgery by prospective multicenter cohort study

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

The rate of margin positive after pre-operative marking using RVS/Vnav in breast conserving surgery for breast cancer with NME

Key secondary outcomes

1) The detection rate of NME in supine MRI
2) The required time to detect the border of the area of NME by using RVS/Vnav
3) The required time to put the breast tissue marker at the border of the area NME
4) The detection rate of the breast tissue marker by the pre-operative ultrasound
5) Operation time and weight of resected specimen in breast conserving surgery,
6) Distance between breast tissue marker and pathological surgical margin
7) The re-operation rate and re-operation operative method


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Fusion imaging technique using Ultrasound ( RVS / Vnav )

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1) A patient who has a breast cancer with NME in breast MRI examination
2) Female aged over 20 years old
3) Performance status 0, 1
4) Agreement on informed consent for this clinical trial

Key exclusion criteria

1) A patient with a pacemaker
2) A patient with allergy for a contrast medium for MRI
3) A patient with a metallic artificial heart valve
4) A patient with past asthmatic symptom
5) A patient with a severe renal dysfunction
6) A patient with a severe claustrophobia
7) A patient with a tattoo
8) A patient who is not able to perform breast MRI with some reasons.
9) A patient who is pregnant or a patient who has a possibility of being pregnant
10) A patient who is lactating
11) A patient who is not able to perform breast conserving surgery
12) A patient who has a history of mental disorder or central nervous disorder
13) A patient who was received neoadjuvant chemotherapy.
14) A patient with allergy for a titanium
15) A patient with allergy for a xylocaine
16) A patient who is not considered suitable by doctors

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shogo
Middle name
Last name Nakano

Organization

Aichi Medical University

Division name

Division of Breast and Endocrine Surgery, Department of Surgery

Zip code

480-1195

Address

1-1 Yazakokarimata, Nagate-city, Aichi, Japan

TEL

0561-62-3311

Email

snakano1@aichi-med-u.ac.jp


Public contact

Name of contact person

1st name Shogo
Middle name
Last name Nakano

Organization

Aichi Medical University

Division name

Division of Breast and Endocrine Surgery, Department of Surgery

Zip code

480-1195

Address

1-1 Yazakokarimata, Nagate-city, Aichi, Japan

TEL

0561-62-3311

Homepage URL


Email

snakano1@aichi-med-u.ac.jp


Sponsor or person

Institute

Aichi Medical University

Institute

Department

Personal name



Funding Source

Organization

Aichi Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aichi Medical University

Address

1-1 Yazakokarimata, Nagate-city, Aichi, Japan

Tel

0561-62-3311

Email

snakano1@aichi-med-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知医科大学病院(愛知県)、大垣市民病院(岐阜県)


Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 02 Month 17 Day

Date of IRB

2019 Year 02 Month 28 Day

Anticipated trial start date

2019 Year 03 Month 12 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 04 Month 18 Day

Last modified on

2020 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041633


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name